chemXplore tracks 18 projects in Turkey, of which 4 are active.
4 new construction.
Expected to start operating, per year; 1 of the active projects carry no start-up date yet.
Owners and developers: ITC (1), Köksan Holding (1), Rönesans Holding (1), SONATRACH (1), Stolt-Nielsen Limited (1)
Investors: Compañía Española de Seguros de Crédito a la Exportación, S.A. (1), ING Groep N.V. (1)
Contractors and licensors are recorded on all 4 of them For subscribers
Targeting: Polypropylene (2), Methane (1), Methanol (1), PET (1), Polyethylene (1), Propane (1)
Expansion at Mazidagi will convert leach residue into iron and slag using rotary kiln pellets and a 30 MVA DRI smelting furnace to cut waste and recover value.
Key concentrator package for a greenfield polymetallic mine in Yozgat province covering comminution, flotation, dewatering and online analytics.
Contracts fund urea licensing, PDP and proprietary equipment across Asia, Europe and North America, plus a feasibility study for a 40,000 t/yr polyolefin upcycling plant.
Revenues 86.3bn manats; total profit 12.6bn and net profit ~3.0bn. EBITDA rose 26%. Major field acquisitions and a 136% jump in operating cash flow.
Revenue driven by crude, petroleum and gas sales; EBITDA rose 26% and net profit ≈AZN 3.0bn amid major field acquisitions and stronger operating cash flow.
Revenue rose 7% to €1,450m while orders fell 16% to €1,498m; EBITA margin 5.3%. Outlook confirmed: revenue €5.4–€5.9bn, FCF €250–€300m (includes Teknokon).
EBIT rises 24% to EUR 260m; free cash flow before acquisitions EUR 61m; full takeover of Turkish JV in April 2026; Middle East conflict tightens base‑oil supply.
Revenue rose 6% to €6,044m and RCO to €1,086m. Strategic acquisitions in North America and Turkey; new 1.25 Mt kiln in France and Padeswood CCS on schedule.
15% stake added to the Kirkuk redevelopment vehicle; ConocoPhillips holds 42%; project targets over 3bn boe across multiple Kirkuk fields; assets currently with NOC/NGC.
Exclusive agreement transfers market development and distribution of GMP-grade REXIM amino acids across most of Europe to a regional distributor, effective July 1, 2026.
